Potential Drug-Drug Interaction (PDDI) CDS IG : STU1 Ballot 2, published by HL7 Clinical Decision Support Workgroup. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/PDDI-CDS/ and changes regularly. See the Directory of published versions

• Narrative Content
• XML
• JSON
• TTL

: valueset-nepafenac-exclude - XML Representation

Raw xml | Download

<ValueSet xmlns="http://hl7.org/fhir">
  <id value="valueset-nepafenac-exclude"/>
  <text>
    <status value="generated"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><ul><li>Include these codes as defined in <a href="http://www.nlm.nih.gov/research/umls/rxnorm"><code>http://www.nlm.nih.gov/research/umls/rxnorm</code></a><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td>603978</td><td>nepafenac 1 MG/ML Ophthalmic Suspension [Nevanac]</td></tr><tr><td>1365866</td><td>nepafenac 3 MG/ML Ophthalmic Suspension [Ilevro]</td></tr><tr><td>603977</td><td>nepafenac Ophthalmic Suspension [Nevanac]</td></tr><tr><td>1365864</td><td>nepafenac Ophthalmic Suspension [Ilevro]</td></tr><tr><td>578044</td><td>nepafenac 1 MG/ML Ophthalmic Suspension</td></tr><tr><td>1362132</td><td>nepafenac 3 MG/ML Ophthalmic Suspension</td></tr><tr><td>578043</td><td>nepafenac Ophthalmic Suspension</td></tr><tr><td>1158407</td><td>nepafenac Ophthalmic Product</td></tr><tr><td>1365865</td><td>Ilevro Ophthalmic Product</td></tr><tr><td>1182860</td><td>Nevanac Ophthalmic Product</td></tr></table></li></ul></div>
  </text>
  <url
       value="http://hl7.org/fhir/uv/pddi/ValueSet/valueset-nepafenac-exclude"/>
  <version value="1.0.0-ballot"/>
  <name value="Valueset_nepafenac_exclude"/>
  <title value="Exclude Nepafenac Medications Value Set"/>
  <status value="draft"/>
  <experimental value="true"/>
  <date value="2018-07-02"/>
  <publisher value="HL7 Clinical Decision Support Workgroup"/>
  <contact>
    <telecom>
      <system value="url"/>
      <value value="http://hl7.org/Special/committees/dss"/>
    </telecom>
  </contact>
  <description
               value="ValueSet containing drug identifiers to exclude. Criteria is explicitly stating topical, gel, cream, ointment, otic, or ophthalmic formulations."/>
  <jurisdiction>
    <coding>
      <system value="http://unstats.un.org/unsd/methods/m49/m49.htm"/>
      <code value="001"/>
    </coding>
  </jurisdiction>
  <purpose value="To refine valueset for Warfarin + NSAID PDDI-CDS"/>
  <copyright value="(copyright expectations unknown)"/>
  <compose>
    <include>
      <system value="http://www.nlm.nih.gov/research/umls/rxnorm"/>
      <concept>
        <code value="603978"/>
        <display value="nepafenac 1 MG/ML Ophthalmic Suspension [Nevanac]"/>
      </concept>
      <concept>
        <code value="1365866"/>
        <display value="nepafenac 3 MG/ML Ophthalmic Suspension [Ilevro]"/>
      </concept>
      <concept>
        <code value="603977"/>
        <display value="nepafenac Ophthalmic Suspension [Nevanac]"/>
      </concept>
      <concept>
        <code value="1365864"/>
        <display value="nepafenac Ophthalmic Suspension [Ilevro]"/>
      </concept>
      <concept>
        <code value="578044"/>
        <display value="nepafenac 1 MG/ML Ophthalmic Suspension"/>
      </concept>
      <concept>
        <code value="1362132"/>
        <display value="nepafenac 3 MG/ML Ophthalmic Suspension"/>
      </concept>
      <concept>
        <code value="578043"/>
        <display value="nepafenac Ophthalmic Suspension"/>
      </concept>
      <concept>
        <code value="1158407"/>
        <display value="nepafenac Ophthalmic Product"/>
      </concept>
      <concept>
        <code value="1365865"/>
        <display value="Ilevro Ophthalmic Product"/>
      </concept>
      <concept>
        <code value="1182860"/>
        <display value="Nevanac Ophthalmic Product"/>
      </concept>
    </include>
  </compose>
</ValueSet>